Cargando…
Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital
BACKGROUND: Cardiotoxicity remains a dreaded complication for patients undergoing chemotherapy with human epidermal growth factor (HER)-2 receptor antagonists and anthracyclines. Though many studies have looked at racial disparities in heart failure patients, minimal data is present for the cardio-o...
Autores principales: | Chen, Crystal B., Dalsania, Raj K., Hamad, Eman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831259/ https://www.ncbi.nlm.nih.gov/pubmed/33494840 http://dx.doi.org/10.1186/s40959-020-00080-w |
Ejemplares similares
-
Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement
por: Ahmad, Javaria, et al.
Publicado: (2022) -
Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
por: Fazal, Muhammad, et al.
Publicado: (2021) -
Overcoming LGBTQI+ Disparities in Cardio-Oncology: A Call to Action
por: Sirufo, Maria Maddalena, et al.
Publicado: (2023) -
PERT era, race‐based healthcare disparities in a large urban safety net hospital
por: Dronamraju, Veena H., et al.
Publicado: (2023) -
Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations
por: Patel, Shruti Rajesh, et al.
Publicado: (2023)